Influence of the first wave of COVID-19 on asthma inhaler prescriptions
Keyword(s):
AbstractIn the beginning of the COVID-19 pandemic, there were major concerns regarding the huge demand for asthma inhalers. Using the primary-care medical records for 614,700 asthma patients between January and June 2020, we found that there was a substantial increase in inhalers solely in March 2020. Patients significantly associated with receiving higher inhaled corticosteroid prescriptions were younger, of higher socioeconomic status, and had milder asthma.
2016 ◽
Vol 16
(1)
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2007 ◽
Vol 20
(2)
◽
pp. 164-173
◽
Keyword(s):
Keyword(s):
Keyword(s):
2017 ◽
Vol 46
(6)
◽
pp. 1948-1957
◽